Interconnection of drug administration systems
In general, interconnection of drug administration systems is provided. In an exemplary embodiment, a drug administration device and a remotely located server can establish a unique key for wireless communication between the device and the server. The drug administration device can be configured to sense information relating to at least one of the device and a drug and can be configured to anonymize data indicative of the sensed information using the key stored in memory of the device. The drug administration device can also be configured to use the key in decrypting data received from the server.
1. A drug administration device configured to retain a drug therein, comprising:
a sensor configured to sense information relating to at least one of the drug administration device and the drug;
a memory configured to store data therein, the stored data including a key and an algorithm including at least one variable parameter, wherein the key is established with a remotely located server, is unique to the drug administration device and the remotely located server, and uniquely identifies a patient associated with the drug administration device;
a communications interface configured to wirelessly transmit data indicative of the sensed information to a remotely located communications interface without any identifying patient information and to wirelessly receive data from the remotely located communications interface; and
a processor configured to use the key to anonymize the data indicative of the sensed information prior to the transmission of the data indicative of the sensed information such that the data does not include any identifying patient information, use the key in decrypting the data received from the remotely located communications interface, use the algorithm in controlling delivery of the drug from the drug administration device to a patient, and to change the at least one variable parameter of the algorithm stored in the memory based on the data received from the remotely located communications interface.
2. The device of claim 1 , wherein the drug administration device is one of a syringe, an injector, an inhaler, a nasal spray device, and an infusion pump.
3. The device of claim 1 , wherein the processor is configured to use the key in anonymizing all data transmitted from the communications interface to the remotely located communications interface.
4. The device of claim 1 , wherein the processor is configured to repeatedly use the key to anonymize multiple sets of data indicative of information sensed by the sensor.
5. The device of claim 1 , wherein the communications interface is configured to wirelessly receive data from the remotely located communications interface.
6. The device of claim 5 , wherein the processor is configured to use the key in decrypting all data received from the remotely located communications interface.
7. The device of claim 1 , wherein the communications interface is configured to wirelessly receive data from the remotely located communications interface, the data includes information regarding proper disposal of the drug administration device after the drug has been delivered from the drug administration device.
8. The device of claim 7 , wherein the processor is configured to cause a notification of the information regarding proper disposal information to be provided to a user of the drug administration device.
9. The device of claim 1 , further comprising a label including information regarding proper disposal of the drug administration device after the drug has been delivered from the drug administration device.
10. The device of claim 1 , wherein the processor is configured to control delivery of the drug from the drug administration device based at least in part on the sensed information.
11. The device of claim 1 , wherein the drug comprises at least one of infliximab, golimumab, ustekinumab, daratumumab, guselkumab, epoetin alfa, risperidone, esketamine, ketamine, and paliperidone palmitate.
12. A drug administration system, comprising:
a server including:
a communications interface configured to wirelessly receive data and wirelessly transmit data,
a memory configured to store a key therein and an algorithm including at least one variable parameter therein, wherein the key uniquely identifies the drug administration device and a patient associated with the drug administration device, and
a processor; and
a drug administration device including:
a memory configured to store the key therein, the key being unique to the drug administration device and the server,
a communications interface configured to wirelessly transmit data to the communications interface of the server without any identifying patient information and to wirelessly receive data from the communications interface of the server, and
a processor;
wherein the processor of the server is configured to use the key to anonymize all data transmitted to the communications interface of the drug administration device prior to the transmission thereof; and
wherein the processor of the drug administration device is configured to use the key to anonymize all data transmitted to the communications interface of the server prior to the transmission thereof such that the data does not include any identifying patient information, to use the key in decrypting the data received from the remotely located communications interface, to use the algorithm in controlling delivery of a drug from the drug administration device to a patient, and to change the at least one variable parameter of the algorithm stored in the memory based on the data received from the remotely located communications interface.
13. The system of claim 12 , wherein the drug administration device is one of a syringe, an injector, an inhaler, a nasal spray device, and an infusion pump.
14. The system of claim 12 , wherein the processor of the server is configured to use the key to decrypt all data received from the communications interface of the drug administration device; and
wherein the processor of the drug administration device is configured to use the key to decrypt all data received from the communications interface of the server.
15. The system of claim 12 , wherein the processor of the server is configured to automatically cause the data received from the communications interface of the drug administration device to be uploaded into at least one of an Electronic Health Record (EHR) of a patient associated with the drug administration device and a patient monitoring form for the drug's Risk Evaluation and Mitigation Strategies (REMS).
16. The system of claim 12 , wherein the drug administration device also includes a sensor configured to sense information relating to at least one of the drug administration device and the drug, and the data transmitted to the communications interface of the server includes data indicative of the sensed information.
17. The system of claim 16 , wherein the processor of the drug administration device is configured to control delivery of the drug from the drug administration device to a patient based at least in part on the sensed information.
18. The system of claim 12 , wherein the data transmitted to communications interface of the server includes data in response to a data request received from the server.
19. The system of claim 12 , wherein the drug comprises at least one of infliximab, golimumab, ustekinumab, daratumumab, guselkumab, epoetin alfa, risperidone, esketamine, ketamine, and paliperidone palmitate.
20. A drug administration method, comprising:
establishing a unique key for wireless communications between a drug administration device and a server located remotely from the drug administration device, the key being stored in a memory of the drug administration device and in a memory of the server, wherein the key uniquely identifies the drug administration device and a patient associated with the drug administration device;
sensing, with a sensor of the drug administration device, information relating to at least one of the drug administration device and a drug;
anonymizing, with a processor of the drug administration device, data indicative of the sensed information using the key stored in the memory of the drug administration device such that the data does not include any identifying patient information; and
using the key stored in the memory of the drug administration device in decrypting, with the processor of the drug administration device, data received from the server;
using an algorithm stored in the memory of the drug administration device to control delivery of a drug from the drug administration device to the patient; and
changing at least one variable parameter of the algorithm stored in the memory based on the data received from the remotely located communications interface.
21. The method of claim 20 , wherein the drug administration device is one of a syringe, an injector, an inhaler, a nasal spray device, and an infusion pump.
22. The method of claim 20 , further comprising, controlling, with the processor of the drug administration device, delivery of the drug from the drug administration device based at least in part on the sensed information.
23. The method of claim 20 , wherein the data includes information regarding proper disposal of the drug delivery device after the drug has been delivered from the drug delivery device.
24. The method of claim 23 , further comprising causing, using the processor, a notification of the information regarding proper disposal information to be provided to a user of the drug administration device.
25. The method of claim 20 , wherein the drug comprises at least one of infliximab, golimumab, ustekinumab, daratumumab, guselkumab, epoetin alfa, risperidone, esketamine, ketamine, and paliperidone palmitate.